Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a

Furber KL, Van Agten M, Evans C, Haddadi A, Doucette JR, Nazarali AJ

Degenerative Neurological and Neuromuscular Disease 2017, 7:47-60

Published Date: 24 March 2017